mounjaro eli lilly tirzepatide Shows Superiority in SURMOUNT-3 and 4 FDA approves new version of

Individuals with diabetes have a higher risk of myocardial infarction (MI), which is more common and carries an increased likelihood of complications and recurrent events compared to those without diabetes

Previous GLP-1 users were far more divided, with 52.34% trusting injections more and 43.75% trusting tablets more, suggesting confidence in tablets may grow once people move away from injectable treatment

Research indicates that combining semaglutide with metformin can improve weight loss, insulin sensitivity, and menstrual regularity

Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 4 randomized clinical trial

In the context of T2D, the management of weight and glycaemic indices is effectively addressed through the practice of structured mindful eating [67]